Centogene N.V. (CNTGF)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostics	33.73M	31.36M	26.59M	21.50M	27.26M
Diagnostics Growth	7.58%	17.92%	23.68%	-21.12%	17.64%
Pharmaceutical	14.80M	16.12M	15.64M	16.95M	21.52M
Pharmaceutical Growth	-8.15%	3.03%	-7.73%	-21.24%	24.35%
Total	48.54M	47.47M	42.23M	38.45M	48.78M
Total Growth	2.24%	12.40%	9.83%	-21.17%	20.51%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2021	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Rest of Europe	7.63M	5.97M	5.70M	5.57M	6.91M
Rest of Europe Growth	27.75%	4.84%	2.39%	-19.51%	19.43%
Germany	95.00K	307.00K	211.00K	186.00K	508.00K
Germany Growth	-69.06%	45.50%	13.44%	-63.39%	-52.12%
Netherlands	2.00K	7.00K	6.00K	3.00K	25.00K
Netherlands Growth	-71.43%	16.67%	100.00%	-88.00%	-
Middle East (Excluding Saudi Arabia)	7.36M	7.49M	6.57M	4.87M	6.68M
Middle East (Excluding Saudi Arabia) Growth	-1.74%	14.06%	34.79%	-27.09%	-3.52%
Saudi Arabia	13.38M	12.41M	9.87M	7.75M	7.42M
Saudi Arabia Growth	7.79%	25.82%	27.26%	4.52%	35.47%
North America (Excluding United States)	40.00K	66.00K	187.00K	206.00K	498.00K
North America (Excluding United States) Growth	-39.39%	-64.71%	-9.22%	-58.63%	-39.05%
United States	14.83M	16.53M	16.40M	17.48M	22.78M
United States Growth	-10.23%	0.79%	-6.17%	-23.28%	31.70%
Latin America	4.31M	3.91M	2.59M	1.89M	2.99M
Latin America Growth	10.21%	50.67%	37.49%	-36.86%	36.70%
Asia Pacific	888.00K	786.00K	711.00K	508.00K	971.00K
Asia Pacific Growth	12.98%	10.55%	39.96%	-47.68%	4.52%
Total	48.54M	47.47M	42.23M	38.45M	48.78M
Total Growth	2.24%	12.41%	9.83%	-21.17%	20.51%

Source: S&P Global Market Intelligence.